PolyPid Ltd

詳細情報 PolyPid Ltd 企業名

Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

企業情報

企業コードPYPD

会社名PolyPid Ltd

上場日Jun 26, 2020

最高経営責任者「CEO」Ms. Dikla Czaczkes Akselbrad

従業員数57

証券種類Ordinary Share

決算期末Jun 26

本社所在地18 Hasivim Street, P.O Box 7126

都市PETAH TIKVA

証券取引所NASDAQ Capital Market Consolidated

国Israel

郵便番号4917002

電話番号972747195700

ウェブサイトhttps://www.polypid.com

企業コードPYPD

上場日Jun 26, 2020

最高経営責任者「CEO」Ms. Dikla Czaczkes Akselbrad

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Yechezkel Barenholz, Ph.D.

Independent Director

2.76K

--

Ms. Dikla Czaczkes Akselbrad

Chief Executive Officer, Director

934.00

+100.00%

Dr. Itzhak Krinsky, Ph.D.

Independent Director

833.00

--

Mr. Jacob Harel

Independent Chairman of the Board

467.00

--

Mr. Ori Warshavsky

Chief Operating Officer - US

267.00

--

Mr. Chaim Hurvitz

Independent Director

--

Dr. Shaul Mukhtar, Ph.D.

Chief Operating Officer, Executive Vice President

--

Ms. Dalit Hazan

Senior Vice President - Research and Development and Regulatory Affairs

--

Dr. Noam Emanuel, Ph.D.

Chief Scientific Officer

--

Dr. Robert Burton (Bob) Stein, M.D., Ph.D.

Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Yechezkel Barenholz, Ph.D.

Independent Director

2.76K

--

Ms. Dikla Czaczkes Akselbrad

Chief Executive Officer, Director

934.00

+100.00%

Dr. Itzhak Krinsky, Ph.D.

Independent Director

833.00

--

Mr. Jacob Harel

Independent Chairman of the Board

467.00

--

Mr. Ori Warshavsky

Chief Operating Officer - US

267.00

--

Mr. Chaim Hurvitz

Independent Director

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Tue, Aug 19

株主統計

種類

株主統計

比率

Aurum Ventures M.K.I.

19.69%

Centaurus Investments Limited

7.08%

Rosalind Advisors, Inc.

6.23%

Worth Venture Partners, LLC

4.67%

Nir (Yehuda)

3.92%

他の

58.41%

株主統計

比率

Aurum Ventures M.K.I.

19.69%

Centaurus Investments Limited

7.08%

Rosalind Advisors, Inc.

6.23%

Worth Venture Partners, LLC

4.67%

Nir (Yehuda)

3.92%

他の

58.41%

種類

株主統計

比率

Venture Capital

19.69%

Hedge Fund

12.56%

Holding Company

7.08%

Individual Investor

5.87%

Investment Advisor/Hedge Fund

4.67%

Corporation

3.76%

Private Equity

2.95%

Investment Advisor

0.79%

Research Firm

0.53%

他の

42.10%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

41

7.60M

74.58%

+1.39M

2025Q1

42

7.66M

75.16%

+942.60K

2024Q4

44

5.48M

65.20%

+1.87M

2024Q3

50

4.47M

69.98%

+1.49M

2024Q2

58

3.43M

73.51%

+1.59M

2024Q1

59

3.33M

71.29%

+2.56M

2023Q4

54

443.78K

34.10%

+80.67K

2023Q3

57

479.04K

37.01%

+97.48K

2023Q2

57

472.86K

36.65%

+91.51K

2023Q1

59

332.36K

28.62%

+89.40K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Aurum Ventures M.K.I.

2.03M

19.88%

+11.34K

+0.56%

Feb 26, 2025

Centaurus Investments Limited

1.11M

10.87%

+475.10K

+75.12%

Dec 31, 2024

Rosalind Advisors, Inc.

1.02M

9.99%

--

Mar 31, 2025

Worth Venture Partners, LLC

429.43K

4.21%

+153.81K

+55.80%

Mar 31, 2025

Nir (Yehuda)

613.91K

6.02%

+62.60K

+11.36%

Mar 31, 2025

Hewlett Fund, L.P.

587.92K

5.77%

+338.44K

+135.66%

Feb 26, 2025

Triple Gate Capital, LP

465.84K

4.57%

+465.84K

--

Feb 26, 2025

AIGH Capital Management, LLC.

510.95K

5.01%

-507.07K

-49.81%

Mar 31, 2025

Lukach (Aharon)

299.55K

2.94%

-5.64K

-1.85%

Mar 31, 2025

Dafna Capital Management, LLC

291.27K

2.86%

--

Mar 31, 2025

詳細を見る

3.450USD

PolyPid Ltd

3.450

概要

企業名

金融

分析